Concepedia

Kirsten Garces

KG

Statistics

Publications

3

Citations

32

H-Index

3

Active since

2001

Affiliations

Amgen (United States)(Current)

Kirsten Garces is an author at Amgen (United States) specializing in pharmacoeconomic modeling, drug approval policy, and immune-mediated inflammatory diseases.

Publications per year

2001–2015

3

Publications

3

Comparative net cost impact of the utilization of romiplostim and intravenous immunoglobulin for the treatment of patients with immune thrombocytopenia in Québec, Canada

M. Pettigrew, Kirsten Garces, Robert Deuson et al. · Journal of Medical Economics · 2012 · 11 citations

, , +17

Anakinra: interleukin-1 receptor antagonist therapy for rheumatoid arthritis.

Kirsten Garces · PubMed · 2001 · 11 citations

, , +17

Improvements in patient‐reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE

Kim Papp, K. Barber, Robert Bissonnette et al. · Journal of the European Academy of Dermatology and Venereology · 2015 · 10 citations · Full text

, , +13

1–3 of 3